10-K: Longwen Group Corp. Reports Full Year 2023 Results, Shifts Focus to Cultural and Health Products

Longwen Group Corp. reports its 2023 financial results, highlighting a strategic shift from aquaculture to cultural and health product sales.

Summary

• Longwen Group Corp., originally incorporated in 1980, reincorporated in Nevada in 2005, and changed its name in 2017, has released its annual report for the fiscal year ended December 31, 2023.
• The company underwent a change of control in 2016, and after a period of seeking mergers and acquisitions, faced delays due to the COVID-19 pandemic.
• In 2022, Longwen acquired Hangzhou Wenyuan Enterprise Management Co., Ltd. and Hangzhou Yusu Trading Co., Ltd. in China for minimal cash consideration.
• In 2023, Longwen established Huzhou Wohong Fishery Co., Ltd. to operate in aquaculture, but due to poor sales, decided to discontinue this operation and sell its assets in March 2024.
• The company's revenue in 2023 was primarily derived from discontinued aquaculture sales, totaling $2,050,313, and consulting services, which generated $15,004.
• Online product sales contributed $6,082 in revenue, while offline product sales generated $2,931.
• Operating expenses for 2023 totaled $1,033,085, an increase from $787,173 in 2022, mainly due to increased share-based compensation and general and administrative expenses.
• The company reported a net loss of $1,026,458 for 2023, compared to a net loss of $746,426 in 2022.
• As of December 31, 2023, Longwen had total assets of $843,723 and a working capital deficit of $335,139.
• The company has shifted its business strategy to focus on cultural and health product sales through its subsidiary HZYS starting in the first quarter of 2024, expecting this to drive revenue growth.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with increased losses, a working capital deficit, and the discontinuation of a major revenue stream. While there is a strategic shift to a new business segment, the company faces significant risks and challenges, leading to a negative sentiment.

Positives

• Online product sales saw a significant increase, growing from $1,788 in 2022 to $6,082 in 2023.
• The company is actively shifting its focus to a new business segment, cultural and health products, which is expected to drive future revenue growth.
• The company has an experienced management team in the cultural and health product sales and project management field.

Negatives

• The company experienced a significant net loss of $1,026,458 in 2023, an increase from $746,426 in 2022.
• The company has a working capital deficit of $335,139 as of December 31, 2023.
• The company's consulting service revenue decreased from $36,418 in 2022 to $15,004 in 2023.
• The aquaculture business, which was a significant revenue source in 2023, was discontinued due to poor sales.

Risks

• The company's ability to continue as a going concern is in doubt due to recurring losses, cash outflow from operations, and an accumulated deficit.
• The company faces significant competition in the cultural and health product market.
• The company relies heavily on its President, and the loss of his services could negatively impact the business.
• The company may require additional capital to support growth, which may not be available on acceptable terms.
• The company may face challenges in establishing adequate management, legal, and financial controls in China.
• The company is subject to complex and rapidly evolving laws and regulations in China.
• The company is subject to risks related to privacy, data security, cybersecurity, and data protection in China.
• The company is subject to risks related to the Chinese government's oversight and discretion over its business operations.
• The company is subject to risks related to changes in China's economic, political, or social conditions.
• The company is subject to risks related to non-compliance with labor-related laws and regulations in China.
• The company is subject to risks related to the PRC legal system, which is sometimes vague and uncertain.
• The company is subject to risks related to governmental control of currency conversion.
• The company is subject to risks related to changes in international trade policies and trade disputes.
• The company is subject to risks related to U.S. regulatory bodies' limited ability to conduct investigations or inspections of its operations in China.
• The company is subject to risks related to the Holding Foreign Companies Accountable Act.
• The company is subject to risks related to the possibility of being classified as a resident enterprise of China.
• The company is subject to risks related to the M&A Rules and other PRC regulations.
• The company is subject to risks related to difficulties in effecting service of legal process, enforcing foreign judgments or bringing actions in China.
• The company is subject to risks related to indirect transfers of equity interests in PRC resident enterprises.
• The company is subject to risks related to the potential dilution of its stock.

Future Outlook

The company expects its newly added cultural and health product sales segment to become a new driving force for revenue growth in 2024.

Management Comments

• The management intends to change its operations due to the change of the economic situation and the sales of aquacultural products is not as expected.
• The management expects the newly added business segment of cultural and health products will become a new driving force for the Companys revenue growth in 2024.
• The company believes its President has the wealth of experience and contacts to help the Company to expand its business.

Industry Context

The cultural and health product market is highly competitive, with many large companies and chain stores providing similar products and services. Longwen Group Corp. is a small, early-stage company that will need to compete effectively with these larger players.

Comparison to Industry Standards

• The company's financial performance, particularly the net loss and working capital deficit, is concerning when compared to industry standards for public companies.
• The company's transition from aquaculture to cultural and health products is a significant strategic shift, and its success will depend on its ability to compete with established players in this market.
• The company's reliance on a single executive and its lack of formal cybersecurity measures are also areas of concern when compared to industry best practices.
• The company's revenue from consulting services is significantly lower than the previous year, indicating a potential weakness in this area of the business.
• The company's share-based compensation is a significant expense, which may be a concern for investors.

Related Party Transactions

• The company borrowed $82,107 from the President of the Company in the first three months of 2022 and an additional $9,676 from July to December 2022.
• The company repaid $16,977 to the President in 2023, with a remaining balance of $71,165 as of December 31, 2023.
• The wife of the President repaid a commercial loan of $14,050 on behalf of the company in the first three months of 2023.
• The company received advances of $156,058 from and repaid $28,330 to the wife of the President in 2023, with a remaining balance of $127,345 as of December 31, 2023.
• The company recognized compensation expenses of $30,976, $16,166, and $22,045 to the President, his wife, and daughter, respectively, in 2023.
• The company purchased inventory totaling $40,373 from Hangzhou Longwen Culture Media Ltd., an entity controlled by the President's daughter.

Stakeholder Impact

• Shareholders face significant risks due to the company's financial instability and going concern issues.
• Employees may be affected by the company's restructuring and potential financial difficulties.
• Customers may experience changes in product offerings as the company shifts its business focus.
• Suppliers may face uncertainty due to the company's financial situation and strategic changes.
• Creditors face increased risk due to the company's working capital deficit and potential inability to repay debts.

Next Steps

• The company will focus on cultural and health product sales through its subsidiary HZYS.
• The company will attempt to improve its business profitability and generate sufficient cash flow from operations.
• The company will execute its business plan to meet its operating needs on a timely basis.
• The company will attempt to raise funds from the issuance of equity and/or debt securities.

Key Dates

Keywords

cultural products, health products, aquaculture, China, financial results, annual report, consulting services, e-commerce, operating expenses, net loss, working capital, share-based compensation, discontinued operations, risk factors, internal controls